C-J Advisory’s Biogen BIIB Stock Holding History

C-J Advisory’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-30	Closed	-$7K	–	170
2019 Q1	$7K	Hold	30	–	–	﹤0.01%	151
2018 Q4	$9K	Hold	30	–	–	0.01%	112
2018 Q3	$11K	Hold	30	–	–	0.01%	116
2018 Q2	$9K	Hold	30	–	–	0.01%	114
2018 Q1	$8K	Hold	30	–	–	0.01%	120
2017 Q4	$10K	Hold	30	–	–	0.01%	112
2017 Q3	$9K	Hold	30	–	–	0.01%	112
2017 Q2	$8K	Hold	30	–	–	0.01%	112
2017 Q1	$8K	Hold	30	–	–	0.01%	107
2016 Q4	$9K	Hold	30	–	–	0.01%	104
2016 Q3	$9K	Buy	+30	New	+$8.88K	0.01%	104

Other funds holding BIIB

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

C-J Advisory's BIIB Position: Q2 2019 in Review

C-J Advisory sold out of Biogen (BIIB) in Q2 2019, closing a stake of 30 shares — an estimated $7K sold.

C-J Advisory first reported a position in BIIB in Q3 2016 and held it in 11 quarters. The position peaked at $11K in Q3 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

C-J Advisory reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
C-J Advisory sold 30 Biogen shares in Q2 2019, an estimated $7K.
C-J Advisory first reported a position in Biogen in Q3 2016 and held it in 11 quarters.
C-J Advisory's Biogen position peaked at $11K in Q3 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on C-J Advisory's 13F filing for Q2 2019, filed 3 Jul 2019.